Delivery Order SPE2DB22D2211-SPE2DB25FRKMF
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,064.82 firm fixed-price delivery order is for REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a Delivery Order valued at $3,277.96 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of REPATHA 140 MG/ML SURECLICKML, a medication, with a completion date of November 22, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,402.64, is a Firm Fixed Price Delivery Order for the supply of REPATHA 140 MG/ML SURECLICK medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,069.72 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 10, 2024 and was not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,588.72 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 18, 2023 and was not set aside for any special category of businesses. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) to supply REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract is a $7,759.50 Firm Fixed Price Delivery Order with a completion date of June 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REPATHA 140 MG/ML SURECLICKML. The $3,139.31 firm-fixed-price delivery order has an ultimate completion date of August 4, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award by the Defense Logistics Agency (DLA) is for the procurement of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product, from the prime contractor Amerisourcebergen Drug Corp. The award, valued at $2,103.96, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The DLA IDC serves as a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of REPATHA 140 MG/ML SURECLICKML. The contract has a ceiling value of $2,211.29 and runs through December 31, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,103.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 3, 2025, with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...